Pacira Pharmaceuticals (PCRX) PT Lowered to $45 at Needham & Company
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $26.47 --0%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
Needham & Company analyst Serge Belanger lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $45.00 (from $52.00) while maintaining a Buy rating.
You May Also Be Interested In
- LVMH (MC:FP) (LVMUY) PT Lowered to EUR570 at Bernstein SocGen Group
- Palo Alto Networks (PANW) PT Raised to $415 at Rosenblatt
- AtriCure Inc. (ATRC) PT Raised to $64 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
